Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Amortizatization of Intangibles (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Amortizatization of Intangibles for 16 consecutive years, with $899000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 34.76% to $899000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.6 million, a 16.99% decrease, with the full-year FY2024 number at $5.4 million, down 2.26% from a year prior.
  • Amortizatization of Intangibles was $899000.0 for Q3 2025 at Harvard Bioscience, down from $1.2 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.6 million in Q4 2022 to a low of $899000.0 in Q3 2025.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2023 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: rose 12.26% in 2022, then crashed 34.76% in 2025.
  • Harvard Bioscience's Amortizatization of Intangibles stood at $1.5 million in 2021, then increased by 12.26% to $1.6 million in 2022, then dropped by 14.91% to $1.4 million in 2023, then fell by 8.36% to $1.3 million in 2024, then decreased by 29.27% to $899000.0 in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Amortizatization of Intangibles are $899000.0 (Q3 2025), $1.2 million (Q2 2025), and $1.2 million (Q1 2025).